The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, February 18, 2021
PTC Therapeutics announced the initiation of the second stage of the FITE19 clinical trial to assess PTC299 in COVID-19 patients.
read more
Wednesday, February 17, 2021
Targovax has announced its lead clinical candidate ONCOS-102 has received Fast-Track designation in malignant pleural mesothelioma from the FDA.
read more
Wednesday, February 17, 2021
Researchers at BGU have developed a novel method for accurately monitoring blood levels of the antipsychotic drug, clozapine, using a blood drop from ...
read more
Tuesday, February 16, 2021
Anixa Biosciences announced animal testing has commenced with two proprietary compounds that have shown potency in in vitro studies.
read more
Tuesday, February 16, 2021
Forge Biologics announced the FDA has granted Fast Track, Orphan Drug, and RPD designations to FBX-101 for the treatment of patients with Krabbe ...
read more
Friday, February 12, 2021
Catapult has announced the FDA has cleared the IND application for its lead product candidate CAP-100, an anti-CCR7 antibody for hematological ...
read more
Friday, February 12, 2021
Sagent announced Camostat mesilate, is one of four therapies being added to the existing ACTIV-2 Adaptive Platform Treatment Trial for Outpatients ...
read more
Friday, February 12, 2021
Novavax announced the start of the rolling review process for authorization of NVX-CoV2373, its COVID-19 vaccine, by multiple regulatory agencies.
read more
Thursday, February 11, 2021
Molecular Templates has entered into a research collaboration with Bristol Myers Squibb to discover and develop multiple novel therapies designed for ...
read more
Wednesday, February 10, 2021
The FDA has granted regular approval to cemiplimab-rwlc for patients with locally advanced basal cell carcinoma.
read more
Wednesday, February 10, 2021
The FDA has issued an EUA for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19.
read more
Wednesday, February 10, 2021
PaxMedica announced positive topline data from its trial PAX-101 as a potential treatment for the core symptoms of Autism.
read more
Tuesday, February 09, 2021
Surface Ophthalmics announced the first patient has been dosed in the trial for SURF-200 for acute dry eye.
read more
Tuesday, February 09, 2021
The FDA approved TEPMETKO for metastatic NSCLC harboring MET exon 14 skipping alterations.
read more
Tuesday, February 09, 2021
AstraZeneca Pharmaceuticals
The KESTREL trial for AstraZeneca’s Imfinzi did not meet the primary endpoint of improving OS versus chemotherapy plus cetuximab in the 1st-line ...
read more